• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制性三氮烯。3. 同系物中的脱烷基化及其与抗肿瘤活性的关系。

Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.

作者信息

Wilman D E, Cox P J, Goddard P M, Hart L I, Merai K, Newell D R

出版信息

J Med Chem. 1984 Jul;27(7):870-4. doi: 10.1021/jm00373a011.

DOI:10.1021/jm00373a011
PMID:6737430
Abstract

The in vivo antitumor activity and in vitro metabolic dealkylation have been measured for an homologous series of 3-alkyl-1-(4-carbamoylphenyl)-3-methyltriazenes and have been compared with their partition coefficients. This investigation has shown that the extent of oxidative metabolism in vitro and the antitumor activity in vivo of these compounds are dependent upon hydrophobicity. These findings provide confirmation for the relationship between metabolism and antitumor activity for aryldialkyltriazenes.

摘要

已测定了一系列3-烷基-1-(4-氨甲酰基苯基)-3-甲基三氮烯的体内抗肿瘤活性和体外代谢脱烷基作用,并将其与它们的分配系数进行了比较。该研究表明,这些化合物的体外氧化代谢程度和体内抗肿瘤活性取决于疏水性。这些发现证实了芳基二烷基三氮烯的代谢与抗肿瘤活性之间的关系。

相似文献

1
Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.肿瘤抑制性三氮烯。3. 同系物中的脱烷基化及其与抗肿瘤活性的关系。
J Med Chem. 1984 Jul;27(7):870-4. doi: 10.1021/jm00373a011.
2
Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.肿瘤抑制性三氮烯。2. 同系物系列中抗肿瘤活性的变化。
J Med Chem. 1980 Sep;23(9):1052-4. doi: 10.1021/jm00183a017.
3
Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties.抗肿瘤三氮烯和三嗪作用模式的研究。6. 1-芳基-3-(羟甲基)-3-甲基三氮烯:合成、化学性质及抗肿瘤特性。
J Med Chem. 1984 Mar;27(3):357-63. doi: 10.1021/jm00369a020.
4
Tumour inhibitory triazenes: structural requirements for an active metabolite.肿瘤抑制性三氮烯:活性代谢物的结构要求
Biochem Pharmacol. 1976 Feb 1;25(3):241-6. doi: 10.1016/0006-2952(76)90207-0.
5
Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives.
J Med Chem. 1977 Jun;20(6):850-3. doi: 10.1021/jm00216a025.
6
Use of cluster analysis in the development of structure-activity relations for antitumor triazenes.
J Med Chem. 1976 Nov;19(11):1299-301. doi: 10.1021/jm00233a009.
7
Studies on the mechanism of action of the tumour inhibitory triazenes.肿瘤抑制性三氮烯作用机制的研究。
Biochem Pharmacol. 1973 Aug 1;22(15):1855-64. doi: 10.1016/0006-2952(73)90045-2.
8
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.抗肿瘤1-(X-芳基)-3,3-二烷基三氮烯。1. 与小鼠L1210白血病相关的定量构效关系
J Med Chem. 1978 Jun;21(6):563-74. doi: 10.1021/jm00204a012.
9
Synthesis, physicochemical properties, and antitumor activities of analogs of 1-phenyl-3-benzyl-3-methyltriazenes.
J Pharm Sci. 1977 Oct;66(10):1416-9. doi: 10.1002/jps.2600661017.
10
Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.
J Med Chem. 1972 Feb;15(2):201-3. doi: 10.1021/jm00272a020.

引用本文的文献

1
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.肝脏代谢诱导剂和抑制剂对二甲基三氮烯抗肿瘤作用的影响。
Cancer Chemother Pharmacol. 1988;21(3):241-5. doi: 10.1007/BF00262778.
2
Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.5-(3-甲基-1-三氮烯基)咪唑-4-甲酰胺(MTIC)对Mer+、Mer+Rem-和Mer-细胞系的细胞毒性:3-乙酰氨基苯甲酰胺的差异增强作用
Br J Cancer. 1988 Jan;57(1):54-8. doi: 10.1038/bjc.1988.8.
3
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
对-(3-甲基-1-三氮烯基)苯甲酸钾盐的抗肿瘤作用,抗转移化合物DM-COOK的单甲基衍生物
Cancer Chemother Pharmacol. 1991;27(6):423-8. doi: 10.1007/BF00685155.